Pharmacokinetics, Pharmacodynamics, and Safety of Nipocalimab in Healthy Chinese Volunteers: A Single-Dose, Phase I Study

Pharmacokinetics, Pharmacodynamics, and Safety of Nipocalimab in Healthy Chinese Volunteers: A Single-Dose, Phase I Study

Abstract Introduction Nipocalimab is a high-affinity, fully human, immunoglobulin G (IgG) 1 monoclonal antibody that inhibits the neonatal Fc receptor. Nipocalimab is under development for the treatment of various IgG autoantibody- and alloantibody-mediated diseases. This study assessed the safety,...

Full description

Saved in:
Bibliographic Details
Main Authors: Haiyan Li, Juanfang Liu, Xiaohong Wang, Weilong Zhao, Lili Zhang, Xiaoye Niu, Jingyao Liu, Zhongqi Dong
Format: Article
Language:English
Published: Adis, Springer Healthcare 2025-05-01
Series:Neurology and Therapy
Subjects:
Autoimmune disease
Chinese
Nipocalimab
Online Access:https://doi.org/10.1007/s40120-025-00763-5
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items